MMED - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

MMED is currently covered by 9 analysts with an average price target of $24.89. This is a potential upside of $8.88 (55.47%) from yesterday's end of day stock price of $16.01.

MMED's activity chart (see below) currently has 0 price targets and 23 ratings on display. The stock rating distribution of MMED is 91.3% BUY and 8.7% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 43.52% of the time, taking 84.89 days on average.

Highest price target for MMED is $28, Lowest price target is $20, average price target is $24.89.

Most recent stock forecast was given by CHRIS PASQUALE from BARCLAYS on 13-Nov-2026. First documented stock forecast 31-Mar-2026.

Currently out of the existing stock ratings of MMED, 21 are a BUY (91.3%), 2 are a HOLD (8.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Oct-2026

$20

$3.99 (24.92%)

$22

9 days ago
(13-Nov-2026)

0/2 (0%)

$2.01 (11.17%)

Buy Since 31-Mar-2026

$28

$11.99 (74.89%)

$26

1 months 14 days ago
(08-Oct-2026)

1/3 (33.33%)

$8.2 (41.41%)

154

Buy Since 31-Mar-2026

$21

$4.99 (31.17%)

$19

2 months 19 days ago
(03-Sep-2026)

2/2 (100%)

$-2.84 (-11.91%)

73

Buy Since 31-Mar-2026

$28

$11.99 (74.89%)

$24

2 months 20 days ago
(02-Sep-2026)

1/4 (25%)

$4.24 (17.85%)

85

Buy Since 31-Mar-2026

$26

$9.99 (62.40%)

$22

2 months 20 days ago
(02-Sep-2026)

1/3 (33.33%)

$2.24 (9.43%)

89

Show more analysts

Please expand the browser size to see the chart

What is MMED average time for price targets to be met?

On average it took 85 days for the stock forecasts to be reached, with an average price target met ratio of 43.52%.

Which analyst most recently updated their price target on MMED?

Christopher Pasquale

Which analyst has the lowest performance score on MMED with a proven track record?

MARIE THIBAULT

Which analyst has the most public recommendations on MMED?

Christopher Pasquale works at BARCLAYS and has 2 price targets and 2 ratings on MMED

Which analyst is the currently most bullish on MMED?

Travis Steed with the highest potential upside of $11.99

Which analyst is the currently most reserved on MMED?

Bruce Jackson with the lowest potential downside of $3.99
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?